Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Terlipressin, Somatostatin, and Octreotide for Acute Variceal Bleeding
NCT00966355Phase 4Completed
- Sponsor
- Korea University
- Start
- Sep 2006
- Primary completion
- May 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of terlipressin, somatostatin and Octreotide long-acting injection in Variceal bleeding (3 arms), sponsored by Korea University. Primary endpoint: 5-day Treatment Failure (Failure to Control Bleeding, Rebleeding, or Death). Started Sep 2006; status: completed.
02
Drugs
terlipressinsomatostatinOctreotide long-acting injection
03
Conditions
Variceal bleeding
Beyond the preview
Go deeper on NCT00966355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966355.